GNC highlights endurance selection
PITTSBURGH GNC on Thursday announced it would highlight its new “Endurance Wall,” which includes as many as 50 SKUs, at two upcoming endurance events.
“The GNC endurance selection is an amazing array of products designed to meet the specific needs of serious athletes across all sports and activities. No matter what their level of experience, GNC has the right product,” stated Tom Dowd, EVP store operations and development.
The new wall will house the on-course drinks for the Ironman World Championship in Kona, Hawaii, on Oct. 9, and from the Bank of America Chicago Marathon on Oct. 10.
“GNC supports a wide range of athletic events around the country, but these two events symbolize the GNC Live Well premise –– that all athletes, whether professionals or serious amateurs, can participate in open events that provide an opportunity for them to demonstrate that their training, with its highs and lows, is worth it all,” stated Dave Sims, GNC VP direct marketing and two-time Hawaii Ironman participant.
In Kona, the PowerBar Ironman Perform is the on-course drink for the race. GNC’s Kona store is only two blocks from the start/finish line and the bike and run components of the race go past it on the way out and coming back. More than 1,800 participants are expected in the Hawaii Ironman event, with thousands more cheering them on.
In Chicago, Gatorade’s G Series Pro 02 endurance formula is the on-course drink for the 33rd running of the marathon. In addition to on-course availability, marathoners and spectators alike will be able to find G Series Pro 02 at GNC stores in the area. As well as the thousands of spectators in downtown Chicago, there will be 38,000 runners, including more than 20,000 from outside Illinois.
NCPA to CMS: Medicaid reimbursements should adhere to healthcare-reform law provisions
ALEXANDRIA, Va. The National Community Pharmacists Association is urging the Centers for Medicare and Medicaid Services to follow guidance that Congress included in the healthcare-reform law in its implementation of a new Medicaid generic drug reimbursement formula based on average manufacturer price, the organization said Tuesday.
CMS recently withdrew provisions that would have dramatically cut Medicaid pharmacy reimbursement to community pharmacies from a previously proposed AMP rule due to an injunction that the NCPA obtained in 2007.
In a letter to Congress, the NCPA recommended giving manufacturers more direction in calculating their AMPs, such as requiring them to only include prices paid by wholesalers for drugs subsequently sold at pharmacies; recognizing the ill effect that the NCPA said curtailed generic drug reimbursements would have on retail pharmacies; and setting up a process by which revised federal upper limits resulting from the revised AMP data will be implemented in order to minimize disruption for patients and pharmacies.
“In many ways, independent community pharmacies are the backbone of Medicaid’s prescription drug benefit,” NCPA acting EVP and CEO Douglas Hoey said. “Pharmacies will become an even more important source of health care-related services for Medicaid beneficiaries as new healthcare reform provisions are implemented.”
David Brailer joins Walgreens’ board of directors
DEERFIELD, Ill. Walgreens has appointed the chairman of Health Evolution Partners to its board of directors.
The drug store chain announced Wednesday that David Brailer would join Walgreens’ board as an independent director, making him the board’s 11th member.
Brailer has served as chairman of Health Evolution Partners since 2006. Prior to joining Health Evolution Partners, he was appointed by the Bush administration as the first national health-information technology coordinator in 2004.
“David’s expertise in advancing healthcare technology on a national level, as well as his experience in supporting companies through investments that promote major change in the health system will provide us with valuable insight,” said Walgreens chairman Alan McNally. “This will be extremely important in the years ahead as technology plays an even greater role in the delivery of quality, affordable and accessible health care.”
Walgreens president and CEO Greg Wasson added, “David will be a tremendous resource to our board and our company as we help patients and payers lower healthcare costs while improving quality, outcomes and transparency through our pharmacy, health and wellness solutions.”